Annual Operating Profit
-$53.29 M
+$32.83 M+38.12%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual operating income is -$53.29 million, with the most recent change of +$32.83 million (+38.12%) on December 31, 2023.
- During the last 3 years, TBPH annual operating profit has risen by +$244.34 million (+82.09%).
- TBPH annual operating profit is now -456.57% below its all-time high of -$9.57 million, reached on December 31, 2012.
Performance
TBPH Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$9.28 M
+$3.48 M+27.28%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly operating income is -$9.28 million, with the most recent change of +$3.48 million (+27.28%) on September 30, 2024.
- Over the past year, TBPH quarterly operating profit has dropped by -$515.00 thousand (-5.88%).
- TBPH quarterly operating profit is now -48.64% below its all-time high of -$6.24 million, reached on December 31, 2023.
Performance
TBPH Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$39.48 M
-$515.00 K-1.32%
September 30, 2024
Summary
- As of February 8, 2025, TBPH TTM operating income is -$39.48 million, with the most recent change of -$515.00 thousand (-1.32%) on September 30, 2024.
- Over the past year, TBPH TTM operating profit has increased by +$25.01 million (+38.78%).
- TBPH TTM operating profit is now -22.70% below its all-time high of -$32.17 million, reached on March 31, 2013.
Performance
TBPH TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
TBPH Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.1% | -5.9% | +38.8% |
| 3 y3 years | +82.1% | +82.1% | +85.7% |
| 5 y5 years | +77.7% | +87.8% | +86.7% |
TBPH Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.3% | -48.6% | +75.5% | -1.3% | +83.4% |
| 5 y | 5-year | at high | +82.1% | -48.6% | +88.9% | -1.3% | +87.2% |
| alltime | all time | -456.6% | +82.1% | -48.6% | +88.9% | -22.7% | +87.2% |
Theravance Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.28 M(-27.3%) | -$39.48 M(+1.3%) |
| Jun 2024 | - | -$12.75 M(+13.8%) | -$38.96 M(-5.3%) |
| Mar 2024 | - | -$11.21 M(+79.6%) | -$41.16 M(-22.8%) |
| Dec 2023 | -$53.29 M(-38.1%) | -$6.24 M(-28.8%) | -$53.29 M(-17.4%) |
| Sep 2023 | - | -$8.76 M(-41.4%) | -$64.48 M(-7.1%) |
| Jun 2023 | - | -$14.95 M(-35.9%) | -$69.42 M(-6.9%) |
| Mar 2023 | - | -$23.34 M(+33.9%) | -$74.56 M(-5.8%) |
| Dec 2022 | -$86.12 M(-65.0%) | -$17.43 M(+27.3%) | -$79.12 M(-20.5%) |
| Sep 2022 | - | -$13.69 M(-31.9%) | -$99.48 M(-27.7%) |
| Jun 2022 | - | -$20.10 M(-28.0%) | -$137.63 M(-24.2%) |
| Mar 2022 | - | -$27.90 M(-26.2%) | -$181.65 M(-23.6%) |
| Dec 2021 | -$246.00 M(-17.3%) | -$37.80 M(-27.1%) | -$237.64 M(-14.0%) |
| Sep 2021 | - | -$51.84 M(-19.1%) | -$276.21 M(-8.2%) |
| Jun 2021 | - | -$64.11 M(-23.6%) | -$300.98 M(-2.6%) |
| Mar 2021 | - | -$83.89 M(+9.9%) | -$309.04 M(+3.8%) |
| Dec 2020 | -$297.63 M(+18.1%) | -$76.36 M(-0.3%) | -$297.63 M(+2.0%) |
| Sep 2020 | - | -$76.61 M(+6.2%) | -$291.84 M(+4.1%) |
| Jun 2020 | - | -$72.18 M(-0.4%) | -$280.43 M(+11.8%) |
| Mar 2020 | - | -$72.48 M(+2.7%) | -$250.72 M(-0.5%) |
| Dec 2019 | -$251.91 M(+5.5%) | -$70.57 M(+8.2%) | -$251.91 M(+3.3%) |
| Sep 2019 | - | -$65.20 M(+53.5%) | -$243.96 M(+1.1%) |
| Jun 2019 | - | -$42.48 M(-42.3%) | -$241.21 M(-2.5%) |
| Mar 2019 | - | -$73.67 M(+17.6%) | -$247.44 M(+3.6%) |
| Dec 2018 | -$238.75 M | -$62.62 M(+0.3%) | -$238.75 M(-6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$62.45 M(+28.2%) | -$255.31 M(+2.2%) |
| Jun 2018 | - | -$48.70 M(-25.0%) | -$249.85 M(-6.2%) |
| Mar 2018 | - | -$64.98 M(-17.9%) | -$266.27 M(+2.4%) |
| Dec 2017 | -$260.12 M(+44.1%) | -$79.18 M(+38.9%) | -$260.12 M(+8.9%) |
| Sep 2017 | - | -$57.00 M(-12.5%) | -$238.78 M(+10.9%) |
| Jun 2017 | - | -$65.12 M(+10.7%) | -$215.28 M(+8.9%) |
| Mar 2017 | - | -$58.83 M(+1.7%) | -$197.65 M(+9.5%) |
| Dec 2016 | -$180.47 M(-0.8%) | -$57.83 M(+72.7%) | -$180.47 M(+1.2%) |
| Sep 2016 | - | -$33.49 M(-29.5%) | -$178.41 M(-5.1%) |
| Jun 2016 | - | -$47.50 M(+14.1%) | -$188.01 M(+1.2%) |
| Mar 2016 | - | -$41.64 M(-25.3%) | -$185.80 M(+2.1%) |
| Dec 2015 | -$181.90 M(-21.8%) | -$55.77 M(+29.4%) | -$181.90 M(-5.2%) |
| Sep 2015 | - | -$43.09 M(-4.9%) | -$191.88 M(-3.5%) |
| Jun 2015 | - | -$45.29 M(+20.0%) | -$198.84 M(-5.4%) |
| Mar 2015 | - | -$37.74 M(-42.6%) | -$210.26 M(-9.6%) |
| Dec 2014 | -$232.54 M(+48.8%) | -$65.75 M(+31.3%) | -$232.54 M(+10.3%) |
| Sep 2014 | - | -$50.06 M(-11.7%) | -$210.87 M(+4.5%) |
| Jun 2014 | - | -$56.71 M(-5.5%) | -$201.88 M(+9.6%) |
| Mar 2014 | - | -$60.02 M(+36.2%) | -$184.13 M(+17.8%) |
| Dec 2013 | -$156.28 M(+1532.2%) | -$44.08 M(+7.3%) | -$156.28 M(+39.3%) |
| Sep 2013 | - | -$41.08 M(+5.5%) | -$112.20 M(+57.8%) |
| Jun 2013 | - | -$38.95 M(+21.1%) | -$71.13 M(+121.1%) |
| Mar 2013 | - | -$32.17 M | -$32.17 M |
| Dec 2012 | -$9.57 M | - | - |
FAQ
- What is Theravance Biopharma annual operating income?
- What is the all time high annual operating profit for Theravance Biopharma?
- What is Theravance Biopharma annual operating profit year-on-year change?
- What is Theravance Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for Theravance Biopharma?
- What is Theravance Biopharma quarterly operating profit year-on-year change?
- What is Theravance Biopharma TTM operating income?
- What is the all time high TTM operating profit for Theravance Biopharma?
- What is Theravance Biopharma TTM operating profit year-on-year change?
What is Theravance Biopharma annual operating income?
The current annual operating profit of TBPH is -$53.29 M
What is the all time high annual operating profit for Theravance Biopharma?
Theravance Biopharma all-time high annual operating income is -$9.57 M
What is Theravance Biopharma annual operating profit year-on-year change?
Over the past year, TBPH annual operating income has changed by +$32.83 M (+38.12%)
What is Theravance Biopharma quarterly operating income?
The current quarterly operating profit of TBPH is -$9.28 M
What is the all time high quarterly operating profit for Theravance Biopharma?
Theravance Biopharma all-time high quarterly operating income is -$6.24 M
What is Theravance Biopharma quarterly operating profit year-on-year change?
Over the past year, TBPH quarterly operating income has changed by -$515.00 K (-5.88%)
What is Theravance Biopharma TTM operating income?
The current TTM operating profit of TBPH is -$39.48 M
What is the all time high TTM operating profit for Theravance Biopharma?
Theravance Biopharma all-time high TTM operating income is -$32.17 M
What is Theravance Biopharma TTM operating profit year-on-year change?
Over the past year, TBPH TTM operating income has changed by +$25.01 M (+38.78%)